Cancer survival rates climb thanks to vaccines, screening, treatment

⁤ Updated June 07, 2025

Significant strides in ‍cancer⁣ treatment and prevention have dramatically improved survival rates, offering new hope to‍ patients. Once ⁢dire‍ diagnoses ⁣are now increasingly ‍manageable, thanks⁤ to advances in vaccines, screening and innovative therapies.

the progress ⁢is evident across various cancers. For instance, the ⁤five-year survival rate ⁣for acute lymphoblastic⁢ leukemia in children has soared from approximately⁤ 10% to over 90%. the five-year survival rate for all⁢ cancers has risen from 49% in the mid-1970s to 69% as of 2019.

Jon⁢ Gluck, diagnosed with multiple myeloma, a blood and bone marrow cancer, in 2003, was initially given only 18 months to live. At the‍ time, the five-year survival rate for myeloma was just 34%. Today,it has nearly doubled to 62%,with many patients living much longer. “There ⁤has been a ⁣revolution‍ in cancer survival,” Gluck said.

Anti-smoking policies have played a crucial role in reducing cancer risk, but other interventions have also ⁣proven effective.the HPV vaccine, for ⁤example, has⁤ led to a 62% drop in cervical cancer deaths among U.S. women ages 20–39 between 2012 and 2021, according ‍to a⁢ recent study. Vaccination can ‍have positive effects on reducing cancer incidence.

Early and improved screening methods also contribute to better outcomes. the earlier cancer⁤ is detected, ⁣the higher the likelihood of ‍survival. From 2000 to 2010, late-stage colorectal cancer cases in Americans over 50‍ decreased by a ⁤third, largely due to increased colonoscopy rates. Newer⁤ screening technologies, including AI and blood-based tests, promise simpler and more accessible preliminary screenings.

Breakthroughs in cancer treatment,such as lenalidomide and bortezomib,have doubled median ‍myeloma survival rates. Monoclonal antibodies have ⁤also significantly ⁢extended ⁣patients’ ⁢lives. ⁤CAR-T therapy, a form of immunotherapy that⁢ turns a patient’s own T-cells⁣ into guided missiles, is especially ‍promising. A recent study showed that a third of ‍multiple myeloma patients, many facing hospice‍ care, experienced no ⁤detectable cancer five years after receiving CAR-T therapy.

“CAR-T is mind-blowing — very science-fiction futuristic,”‍ Gluck ⁤said, who underwent the treatment in mid-2023. He added that the experience, which put his cancer into remission, left him feeling‍ “physically and metaphysically ⁤new.”

Despite these advancements,challenges ⁤remain,including rising rates of gastrointestinal cancers among younger ⁤people. However, the future of cancer treatment continues to improve, offering new hope and extended lives for patients.

What’s next

Ongoing research and progress in⁤ cancer therapies promise further improvements in survival rates and⁣ quality of life for patients. ⁣While‍ uncertainty remains a part of living with cancer, the progress made offers a more optimistic outlook than ever before.